<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04729855</url>
  </required_header>
  <id_info>
    <org_study_id>Esraa Hassan MD Protocol</org_study_id>
    <nct_id>NCT04729855</nct_id>
  </id_info>
  <brief_title>Association of Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer in Egyptian Population</brief_title>
  <official_title>Association of Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer in Egyptian Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Esraa Hassan,MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>South Egypt Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Determination of serum expression level of HOTTIP and EIF4EBP1(Eukaryotic translation&#xD;
           initiation factor 4E-binding protein 1) .&#xD;
&#xD;
        2. Investigation of the SNP HOTTIP rs1859168 and it's association with CRC susceptibility.&#xD;
&#xD;
        3. Determination of serum level of Interleukin -6 and its relation to other studied genes.&#xD;
&#xD;
        4. Correlation of the expression of these genes with various stages of CRC to determine the&#xD;
           prognostic value of each of them.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Colorectal cancer (CRC) is a common digestive tract tumor 1.It is the third leading cause of&#xD;
      death in the world. Overall 5-year survival rate is less than 40%, and the occurrence is&#xD;
      rising 2. However, the prognosis and therapy have not been significantly improved. Therefore,&#xD;
      a proper selection of patients for aggressive treatment is necessary, new therapeutic and&#xD;
      prognostic strategies are urgently needed 3.&#xD;
&#xD;
      Autophagy is a pathway for self-digestion, in which unwanted cytoplasmic components are&#xD;
      recycled 4.In normal conditions, autophagy is essential for cellular homeostasis 5. Autophagy&#xD;
      has dual roles in cancer cells, stimulation or suppression , with effects on progression and&#xD;
      oncogenesis 6.Recent research established that autophagy is important target for controlling&#xD;
      cancer depending on stage and type of tumor 7.Diverse molecular mechanisms contribute to&#xD;
      cancer cells resistance to treatment 8.Among these mechanisms , autophagy appears to be&#xD;
      critical 9.&#xD;
&#xD;
      EIF4EBP1 (Eukaryotic translation initiation factor 4E-binding protein 1) is encoded by&#xD;
      EIF4EBP1 gene.It acts as an effector in mTOR (mammilian target of rapamycin) pathway which on&#xD;
      activation ,EIF4EBP1 is phosphorylated promoting cell proliferation 10. Studies have&#xD;
      suggested that EIF4EBP1 promotes carcinogenesis as in hepatocellular carcinoma .However, its&#xD;
      role in CRC have not been elucidated 10.&#xD;
&#xD;
      Long non-coding RNAs (lncRNAs) are group of RNA , 200 nucleotides in length 11,. Expression&#xD;
      of lncRNAs has been discovered in multiple tumors, acting as oncogenes. 'HOXA(hydrogenase&#xD;
      transcriptional regulatory protein) transcript at the distal tip' (HOTTIP) has received&#xD;
      attention lately.It is up-regulated in CRC tissue, regulating genes via epigenetic&#xD;
      modification. Therefore, it might be a candidate for cancerization and therapy of CRC 12.&#xD;
&#xD;
      Expression of lncRNAs could be affected by single nucleotide polymorphisms (SNPs), the most&#xD;
      common genetic variation in human genomes13. rs1859168 was reported as a potential functional&#xD;
      polymorphism on HOTTIP that alters its expression level 14.. Also, it was recently reported&#xD;
      that HOTTIP enhances interleukin 6 expression, which potentiates immune escape of cancer&#xD;
      cells 15.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 15, 2021</start_date>
  <completion_date type="Anticipated">April 20, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 20, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HOTTIP gene expression</measure>
    <time_frame>2 years</time_frame>
    <description>Estimation of expression level of HOTTIP in peripheral blood mononuclear cells aiming to use as possible less invasive prognostic markers for colorectal cancer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EIF4EBP</measure>
    <time_frame>2 years</time_frame>
    <description>Estimation of expression level of EIF4EBP in peripheral blood mononuclear cells</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">148</enrollment>
  <condition>Colo-rectal Cancer</condition>
  <arm_group>
    <arm_group_label>colorectal cancer patients</arm_group_label>
    <description>Colorectal cancer patients( n = 74 ) from stage I-III with the following criteria:-&#xD;
a. Inclusion criteria:&#xD;
No sex predilection.&#xD;
Age (25-65 yr).&#xD;
Colorectal carcinoma confirmed by histopathological examination</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls ( n = 74)</arm_group_label>
    <description>matched as regarding age and sex as much as possible with cases.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>serum HOTTIP ,EIF4EBP1 and serum SNP HOTTIP rs1859168</intervention_name>
    <description>5 ml fresh blood sample</description>
    <arm_group_label>Healthy controls ( n = 74)</arm_group_label>
    <arm_group_label>colorectal cancer patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      EDTA (ethylene diamine tetra acetic acid)coated fresh blood sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy controls ( n = 74) matched as regarding age and sex as much as possible with cases.&#xD;
&#xD;
        -Colorectal cancer patients( n = 74 ) from stage I-III with the following criteria:-&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  No sex predilection.&#xD;
&#xD;
          -  Age (25-65 yr).&#xD;
&#xD;
          -  Colorectal carcinoma confirmed by histopathological examination&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  -patients who received any treatment.&#xD;
&#xD;
          -  Cases with other organ cancers.&#xD;
&#xD;
          -  History of chemotherapy and radiotherapy.&#xD;
&#xD;
          -  Systemic diseases such as renal failure, diabetes mellitus, and hypertension.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Esraa H Mohamed, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant lecturer of Medical Microbiology and Immunology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Esraa H Mohamed, Master</last_name>
    <phone>01006306349</phone>
    <email>dresraahassan91@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ailaa A Ghandour, MD</last_name>
  </overall_contact_backup>
  <reference>
    <citation>Chisanga D, Keerthikumar S, Pathan M, Ariyaratne D, Kalra H, Boukouris S, Mathew NA, Al Saffar H, Gangoda L, Ang CS, Sieber OM, Mariadason JM, Dasgupta R, Chilamkurti N, Mathivanan S. Colorectal cancer atlas: An integrative resource for genomic and proteomic annotations from colorectal cancer cell lines and tissues. Nucleic Acids Res. 2016 Jan 4;44(D1):D969-74. doi: 10.1093/nar/gkv1097. Epub 2015 Oct 22.</citation>
    <PMID>26496946</PMID>
  </reference>
  <reference>
    <citation>Yang M, Zhao H, Guo L, Zhang Q, Zhao L, Bai S, Zhang M, Xu S, Wang F, Wang X, Zhao B. Autophagy-based survival prognosis in human colorectal carcinoma. Oncotarget. 2015 Mar 30;6(9):7084-103.</citation>
    <PMID>25762626</PMID>
  </reference>
  <reference>
    <citation>Katheder NS, Khezri R, O'Farrell F, Schultz SW, Jain A, Rahman MM, Schink KO, Theodossiou TA, Johansen T, Juh√°sz G, Bilder D, Brech A, Stenmark H, Rusten TE. Microenvironmental autophagy promotes tumour growth. Nature. 2017 Jan 19;541(7637):417-420. doi: 10.1038/nature20815. Epub 2017 Jan 11.</citation>
    <PMID>28077876</PMID>
  </reference>
  <reference>
    <citation>Rahman MA, Rhim H. Therapeutic implication of autophagy in neurodegenerative diseases. BMB Rep. 2017 Jul;50(7):345-354. Review.</citation>
    <PMID>28454606</PMID>
  </reference>
  <reference>
    <citation>Uddin MS, Stachowiak A, Mamun AA, Tzvetkov NT, Takeda S, Atanasov AG, Bergantin LB, Abdel-Daim MM, Stankiewicz AM. Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications. Front Aging Neurosci. 2018 Jan 30;10:04. doi: 10.3389/fnagi.2018.00004. eCollection 2018. Review.</citation>
    <PMID>29441009</PMID>
  </reference>
  <reference>
    <citation>√Åvalos Y, Canales J, Bravo-Sagua R, Criollo A, Lavandero S, Quest AF. Tumor suppression and promotion by autophagy. Biomed Res Int. 2014;2014:603980. doi: 10.1155/2014/603980. Epub 2014 Sep 18. Review.</citation>
    <PMID>25328887</PMID>
  </reference>
  <reference>
    <citation>Abdullah LN, Chow EK. Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med. 2013 Jan 17;2(1):3. doi: 10.1186/2001-1326-2-3.</citation>
    <PMID>23369605</PMID>
  </reference>
  <reference>
    <citation>Ojha R, Bhattacharyya S, Singh SK. Autophagy in Cancer Stem Cells: A Potential Link Between Chemoresistance, Recurrence, and Metastasis. Biores Open Access. 2015 Jan 1;4(1):97-108. doi: 10.1089/biores.2014.0035. eCollection 2015. Review.</citation>
    <PMID>26309786</PMID>
  </reference>
  <reference>
    <citation>Cha YL, Li PD, Yuan LJ, Zhang MY, Zhang YJ, Rao HL, Zhang HZ, Zheng XF, Wang HY. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma. PLoS One. 2015 Feb 6;10(2):e0117493. doi: 10.1371/journal.pone.0117493. eCollection 2015.</citation>
    <PMID>25658620</PMID>
  </reference>
  <reference>
    <citation>Bonasio R, Shiekhattar R. Regulation of transcription by long noncoding RNAs. Annu Rev Genet. 2014;48:433-55. doi: 10.1146/annurev-genet-120213-092323. Epub 2014 Sep 18. Review.</citation>
    <PMID>25251851</PMID>
  </reference>
  <reference>
    <citation>Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta RA, Wysocka J, Lei M, Dekker J, Helms JA, Chang HY. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011 Apr 7;472(7341):120-4. doi: 10.1038/nature09819. Epub 2011 Mar 20.</citation>
    <PMID>21423168</PMID>
  </reference>
  <reference>
    <citation>Lv Z, Xu Q, Yuan Y. A systematic review and meta-analysis of the association between long non-coding RNA polymorphisms and cancer risk. Mutat Res Rev Mutat Res. 2017 Jan - Mar;771:1-14. doi: 10.1016/j.mrrev.2016.10.002. Epub 2016 Nov 5. Review.</citation>
    <PMID>28342449</PMID>
  </reference>
  <reference>
    <citation>Hu P, Qiao O, Wang J, Li J, Jin H, Li Z, Jin Y. rs1859168 A &gt; C polymorphism regulates HOTTIP expression and reduces risk of pancreatic cancer in a Chinese population. World J Surg Oncol. 2017 Aug 17;15(1):155. doi: 10.1186/s12957-017-1218-0.</citation>
    <PMID>28818070</PMID>
  </reference>
  <reference>
    <citation>Shang A, Wang W, Gu C, Chen C, Zeng B, Yang Y, Ji P, Sun J, Wu J, Lu W, Sun Z, Li D. Correction to: Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils. J Exp Clin Cancer Res. 2020 Dec 4;39(1):272. doi: 10.1186/s13046-020-01755-z.</citation>
    <PMID>33272287</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 24, 2021</study_first_submitted>
  <study_first_submitted_qc>January 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2021</study_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Esraa Hassan,MD</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <keyword>Colorectal cancer, HOTTIP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>all researchers will have access to individual patient data with preserving confidentiality</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

